David C Wedge

David C Wedge

Manchester University

H-index: 72

North America-United States

About David C Wedge

David C Wedge, With an exceptional h-index of 72 and a recent h-index of 64 (since 2020), a distinguished researcher at Manchester University, specializes in the field of Cancer Genomics, Cancer Evolution, Data Science, Multiomics, Equality Diversity and Inclusion.

His recent articles reflect a diverse array of research interests and contributions to the field:

AmplificationTimeR: An R Package for Timing Sequential Amplification Events

Abstract A006: Cancer origin tracing and timing in two high risk prostate cancers using multisample whole genome analysis: Potential clinical value

KRAS mutant lung adenocarcinoma is associated with distinct mutational signature profiles

Abstract LB228: Evolutionary trajectories of lung cancer in never smokers

RAS-Bio a unique pan-cancer biobank for RAS-driven tumors

Abstract LB226: Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition

Genomic evolution shapes prostate cancer disease type

APOBEC shapes tumor evolution and age at onset of lung cancer in smokers

David C Wedge Information

University

Position

Professor of Cancer Genomics and Data Science

Citations(all)

46079

Citations(since 2020)

27938

Cited By

30718

hIndex(all)

72

hIndex(since 2020)

64

i10Index(all)

122

i10Index(since 2020)

110

Email

University Profile Page

Google Scholar

David C Wedge Skills & Research Interests

Cancer Genomics

Cancer Evolution

Data Science

Multiomics

Equality Diversity and Inclusion

Top articles of David C Wedge

Title

Journal

Author(s)

Publication Date

AmplificationTimeR: An R Package for Timing Sequential Amplification Events

Bioinformatics

G Maria Jakobsdottir

Stefan C Dentro

Robert G Bristow

David C Wedge

2024/4/24

Abstract A006: Cancer origin tracing and timing in two high risk prostate cancers using multisample whole genome analysis: Potential clinical value

Cancer Research

Anssi Nurminen

Serafiina Jaatinen

Sinja Taavitsainen

Gunilla Högnäs

Tom Lesluyes

...

2024/2/1

KRAS mutant lung adenocarcinoma is associated with distinct mutational signature profiles

Cancer Research

Laura Woodhouse

Aliah Hawari

Andreas Gruber

Colin Lindsay

David Wedge

2024/3/22

Abstract LB228: Evolutionary trajectories of lung cancer in never smokers

Cancer Research

Christopher Wirth

Tongwu Zhang

Wei Zhao

Phuc Hoang

Jian Sang

...

2024/4/5

RAS-Bio a unique pan-cancer biobank for RAS-driven tumors

Cancer Research

Mathew Carter

Katherine D Brown

Helen Adderley

George Morrissey

Laura Woodhouse

...

2024/3/22

Abstract LB226: Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotransposition

Cancer Research

Tongwu Zhang

Wei Zhao

Christopher Wirth

Marcos Díaz-Gay

Jinhu Yin

...

2024/4/5

Genomic evolution shapes prostate cancer disease type

Cell Genomics

Dan J Woodcock

Atef Sahli

Ruxandra Teslo

Vinayak Bhandari

Andreas J Gruber

...

2024/2/29

APOBEC shapes tumor evolution and age at onset of lung cancer in smokers

bioRxiv

Tongwu Zhang

Jian Sang

Phuc H Hoang

Wei Zhao

Jennifer Rosenbaum

...

2024/4/3

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with …

Genome Medicine

Srinivasa Rao

Clare Verrill

Lucia Cerundolo

Nasullah Khalid Alham

Zeynep Kaya

...

2024/12

Ultra-sensitive detection of circulating tumour DNA enriches for patients with greater risk of recurrence in clinically localised prostate cancer

European Urology

Bernard Pope

Gahee Park

Edmund Lau

Jelena Belic

Radoslaw Lach

...

2024/2/19

Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival

bioRxiv

Michael J Haley

Leoma Bere

James Minshull

Sokratia Georgaka

Natalia Garcia-Martin

...

2023

Abstract PO5-25-12: CDH1 mutations predict resistance to neoadjuvant taxane therapy

Cancer Research

Stian Knappskog

Reham Helwa

Sivaramakrishna Rachakonda

Liv B Gansmo

Carsten Denkert

...

2024/5/2

Cancer origin tracing and timing in two high risk prostate cancers using multisample whole genome analysis: Potential clinical value

Genome medicine

Anssi Nurminen

Serafiina Jaatinen

Sinja Taavitsainen

Gunilla Högnäs

Tom Lesluyes

...

2023/10/12

Characterizing HRD in ovarian cancer: Insights from copy number signatures

Cancer Research

Aliah Hawari

Avraam Tapinos

Claire J Kramer

Andreas J Gruber

Richard Houlston

...

2024/3/22

Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients.

medRxiv

Andrew Everall

Avraam Tapinos

Aliah Hawari

Alex Cornish

Amit Sud

...

2023

The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia

Leukemia

Luz Yurany Moreno Rueda

Dean Bryant

William J Tapper

Nicola J Weston-Bell

David C Wedge

...

2023/4

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Nature genetics

Isidro Cortés-Ciriano

Jake June-Koo Lee

Ruibin Xi

Dhawal Jain

Youngsook L Jung

...

2023/6

Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (vol 52, pg 306, 2020)

NATURE GENETICS

Bernardo Rodriguez-Martin

Eva G Alvarez

Adrian Baez-Ortega

Jorge Zamora

Fran Supek

...

2023/3/21

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

Research Square

Richard Houlston

Richard Culliford

Sam Lawrence

Charlie Mills

Zayd Tippu

...

2023/12/6

APOBEC deaminases compete with tobacco smoking mutagenesis and affect age at onset of lung cancer

Cancer Research

Tongwu Zhang

Jian Sang

Phuc H Hoang

Wei Zhao

Jennifer Rosenbaum

...

2023/4/4

See List of Professors in David C Wedge University(Manchester University)

Co-Authors

academic-engine